Results suggest that the expressions of miR-96, miR-182, and miR-183 in tumor and sera may be considered potential novel biomarkers for the diagnosis and prognosis of lung cancer.

This study suggested that miR-183-3p expression might be involved in lung cancer pathogenesis and progression

The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.

High mir-183 expression is associated with non-small cell lung cancer.

miR-183 may act as a potential tumor oncogene in lung adenocarcinomas.

our data indicate that miR-183 plays a pro-invasive role by inverse regulation of PTPN4, and this axis may be a new therapeutic target for suppressing the metastatic capability of cancer stem-like cells in non-small cell lung cancer .

Combination of miR-19b and miR-183 provided detection of lung cancer with 94.7% sensitivity and 95.2% specificity

High miR-183 is associated with invasive lung adenocarcinoma.

we conclude that miR1835p acts as an oncogene in lung adenocarcinoma and participates in the pathogenesis of lung adenocarcinoma via the interaction networks of its target genes

miR-183 promotes radioresistance of lung adenocarcinoma H1299 cells via epithelial-mesenchymal transition.